• Treatment for covid-19 using Tocilizumab

    Asked by WNMyeloma on Sunday, April 5, 2020

    Treatment for covid-19 using Tocilizumab

    A case study of a patient in Wuhan, China, suggests that the immunosuppressant tocilizumab may be an effective COVID-19 treatment for very ill patients who also have multiple myeloma and other blood cancers


    1 Answer from the Community

    • po18guy's Avatar

      Very interesting at this early date, and it makes sense. Immunosuppressed patients are facing the double-edged sword of having less chance of a cytokine storm, but also less chance for the weakened immune system to fight the underlying virus. And, one rare lymphoma (Angioimmunoblastic T-Cell Lymphoma, or AITL) causes a cytokine storm which produces a bewildering array of auto-immune symptoms, to include pleural effusions and pneumonia-like symptoms. It would seem that this would be a very challenging case to treat. One Korean Professor on the front line of viral epidemics, has stated that re-purposing existing drugs may be the quickest method of dealing with Covid-19. This study seems to reflect that.

      about 1 month ago

    Help the community by answering this question:

    Create an account to post your answer Already have an account? Sign in!

    By using WhatNext, you agree to our User Agreement, and Privacy Policy

    Read and answer more multiple myeloma questions.  Also, don't forget to check out our Multiple Myeloma page.